{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:02:23Z","timestamp":1789732943355,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","nanomedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.nano.2015.07.011","type":"journal-article","created":{"date-parts":[[2015,8,15]],"date-time":"2015-08-15T13:45:23Z","timestamp":1439646323000},"page":"2003-2012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Assessment of \u03b2-lapachone loaded in lecithin-chitosan nanoparticles for the topical treatment of cutaneous leishmaniasis in L. major infected BALB\/c mice"],"prefix":"10.1016","volume":"11","author":[{"given":"Esther","family":"Moreno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juana","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Larrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iosune","family":"Conde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Font","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Sanmart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Irache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Socorro","family":"Espuelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2015.07.011_bb0005","first-page":"1","article-title":"Control of the leishmaniasis: report of a meeting of the WHO Expert Committee on the Control of Leishmaniasis, Geneva, 22\u201326 March 2010","volume":"949","year":"2010"},{"key":"10.1016\/j.nano.2015.07.011_bb0010","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","article-title":"Cutaneous leishmaniasis","volume":"7","author":"Reithinger","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.nano.2015.07.011_bb0015","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s40265-013-0132-1","article-title":"Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis","volume":"73","author":"Monge-Maillo","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.nano.2015.07.011_bb0020","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1529-8019.2009.01272.x","article-title":"Cutaneous and mucocutaneous leishmaniasis","volume":"22","author":"David","year":"2009","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.nano.2015.07.011_bb0025","doi-asserted-by":"crossref","first-page":"e381","DOI":"10.1371\/journal.pntd.0000381","article-title":"Is paromomycin an effective and safe treatment against cutaneous leishmaniasis? A meta-analysis of 14 randomized controlled trials","volume":"3","author":"Kim","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.nano.2015.07.011_bb0030","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJMoa1202657","article-title":"Topical paromomycin with or without gentamicin for cutaneous leishmaniasis","volume":"368","author":"Ben Salah","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nano.2015.07.011_bb0035","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4269\/ajtmh.12-0736","article-title":"Randomized, double-blinded, phase 2 trial of WR 279,396 (paromomycin and gentamicin) for cutaneous leishmaniasis in Panama","volume":"89","author":"Sosa","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.nano.2015.07.011_bb0040","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1517\/17425247.2014.885500","article-title":"Nanoparticles as multifunctional devices for the topical treatment of cutaneous leishmaniasis","volume":"11","author":"Moreno","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.nano.2015.07.011_bb0045","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/1874848100902010042","article-title":"Preclinical and clinical studies of Lapachol and Beta-lapachone","volume":"2","author":"de Almeida","year":"2009","journal-title":"Open Natural Prod J"},{"key":"10.1016\/j.nano.2015.07.011_bb0050","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ejmech.2013.02.038","article-title":"Potent naphthoquinones against antimony-sensitive and -resistant Leishmania parasites: synthesis of novel alpha- and nor-alpha-lapachone-based 1,2,3-triazoles by copper-catalyzed azide-alkyne cycloaddition","volume":"63","author":"Guimaraes","year":"2013","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.nano.2015.07.011_bb0055","first-page":"905","article-title":"beta-Lapachone accelerates the recovery of burn-wound skin","volume":"26","author":"Fu","year":"2011","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.nano.2015.07.011_bb0060","doi-asserted-by":"crossref","first-page":"C931","DOI":"10.1152\/ajpcell.00266.2008","article-title":"In vitro and in vivo wound healing-promoting activities of beta-lapachone","volume":"295","author":"Kung","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.nano.2015.07.011_bb0065","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1517\/17425247.4.6.579","article-title":"Vesicles as tools for the modulation of skin permeability","volume":"4","author":"Dubey","year":"2007","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.nano.2015.07.011_bb0070","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1517\/17425247.2012.686490","article-title":"Nanocarrier-based topical drug delivery for the treatment of skin diseases","volume":"9","author":"Gupta","year":"2012","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.nano.2015.07.011_bb0075","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jconrel.2009.11.013","article-title":"Lecithin\/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin","volume":"142","author":"Senyigit","year":"2010","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2015.07.011_bb0080","first-page":"1621","article-title":"Preparation and evaluation of quercetin-loaded lecithin-chitosan nanoparticles for topical delivery","volume":"6","author":"Tan","year":"2011","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2015.07.011_bb0085","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2147\/IJN.S40519","article-title":"Enhanced dermal delivery of diflucortolone valerate using lecithin\/chitosan nanoparticles: in-vitro and in-vivo evaluations","volume":"8","author":"Ozcan","year":"2013","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2015.07.011_bb0090","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijpharm.2006.06.036","article-title":"Formation of self-organized nanoparticles by lecithin\/chitosan ionic interaction","volume":"324","author":"Sonvico","year":"2006","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2015.07.011_bb0095","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0022-1759(92)90191-U","article-title":"A new and simple method for studying the binding and ingestion steps in the phagocytosis of yeasts","volume":"154","author":"Giaimis","year":"1992","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.nano.2015.07.011_bb0100","doi-asserted-by":"crossref","first-page":"e40350","DOI":"10.1371\/journal.pone.0040350","article-title":"Glycerol monolaurate antibacterial activity in broth and biofilm cultures","volume":"7","author":"Schlievert","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2015.07.011_bb0105","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1128\/AAC.03305-14","article-title":"Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani","volume":"59","author":"Sinha","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nano.2015.07.011_bb0110","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ijpharm.2009.07.038","article-title":"Study on the mechanisms of chitosan and its derivatives used as transdermal penetration enhancers","volume":"382","author":"He","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2015.07.011_bb0115","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1172\/JCI72058","article-title":"Collective nitric oxide production provides tissue-wide immunity during Leishmania infection","volume":"124","author":"Olekhnovitch","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nano.2015.07.011_bb0120","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.addr.2012.05.009","article-title":"Cationic lipids activate intracellular signaling pathways","volume":"64","author":"Lonez","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2015.07.011_bb0125","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1128\/AAC.01984-12","article-title":"Immunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B-encapsulated nanoemulsion template-based chitosan nanocapsules","volume":"57","author":"Asthana","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nano.2015.07.011_bb0130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1164\/rccm.200209-1051OC","article-title":"beta-Lapachone reduces endotoxin-induced macrophage activation and lung edema and mortality","volume":"168","author":"Tzeng","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.nano.2015.07.011_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005067.pub3","article-title":"Interventions for Old World cutaneous leishmaniasis","author":"Gonzalez","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nano.2015.07.011_bb0140","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1086\/314782","article-title":"Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: efficacy and mode of action","volume":"179","author":"Buates","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.nano.2015.07.011_bb0145","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.exppara.2006.12.004","article-title":"Leishmania major: in vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod","volume":"116","author":"El-On","year":"2007","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.nano.2015.07.011_bb0150","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.intimp.2011.08.002","article-title":"Immunomodulation by chemotherapeutic agents against leishmaniasis","volume":"11","author":"Saha","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.nano.2015.07.011_bb0155","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/infdis\/jit378","article-title":"A targeted and adjuvanted nanocarrier lowers the effective dose of liposomal amphotericin B and enhances adaptive immunity in murine cutaneous leishmaniasis","volume":"208","author":"Daftarian","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.nano.2015.07.011_bb0160","doi-asserted-by":"crossref","first-page":"e18467","DOI":"10.1371\/journal.pone.0018467","article-title":"Berberine chloride mediates its anti-leishmanial activity via differential regulation of the mitogen activated protein kinase pathway in macrophages","volume":"6","author":"Saha","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2015.07.011_bb0165","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.4049\/jimmunol.175.2.1161","article-title":"18 Beta-glycyrrhetinic acid triggers curative Th1 response and nitric oxide up-regulation in experimental visceral leishmaniasis associated with the activation of NF-kappa B","volume":"175","author":"Ukil","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2015.07.011_bb0170","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbrc.2012.12.143","article-title":"Inhibitory effects of berberine on lipopolysaccharide-induced inducible nitric oxide synthase and the high-mobility group box 1 release in macrophages","volume":"431","author":"Lee","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nano.2015.07.011_bb0175","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbrc.2011.11.143","article-title":"Analysis of the synergistic effect of glycyrrhizin and other constituents in licorice extract on lipopolysaccharide-induced nitric oxide production using knock-out extract","volume":"417","author":"Uto","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nano.2015.07.011_bb0180","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1586\/eri.11.59","article-title":"Chitosan preparations for wounds and burns: antimicrobial and wound-healing effects","volume":"9","author":"Dai","year":"2011","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"10.1016\/j.nano.2015.07.011_bb0185","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/0142-9612(94)90272-0","article-title":"Chitosan-mediated stimulation of macrophage function","volume":"15","author":"Peluso","year":"1994","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2015.07.011_bb0190","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1016\/S0142-9612(01)00042-4","article-title":"The effect of chitin and chitosan on the proliferation of human skin fibroblasts and keratinocytes in vitro","volume":"22","author":"Howling","year":"2001","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2015.07.011_bb0195","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/pim.12007","article-title":"Tissue damage and immunity in cutaneous leishmaniasis","volume":"34","author":"Nylen","year":"2012","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.nano.2015.07.011_bb0200","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.intimp.2006.12.006","article-title":"Anti-inflammatory effects of beta-lapachone in lipopolysaccharide-stimulated BV2 microglia","volume":"7","author":"Moon","year":"2007","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.nano.2015.07.011_bb0205","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ejcb.2010.04.008","article-title":"Interleukin-1, inflammasomes and the skin","volume":"89","author":"Feldmeyer","year":"2010","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.nano.2015.07.011_bb0210","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.immuni.2009.04.012","article-title":"A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses","volume":"30","author":"Meng","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.nano.2015.07.011_bb0215","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.smim.2015.03.014","article-title":"The resolution of inflammation: principles and challenges","volume":"27","author":"Headland","year":"2015","journal-title":"Semin Immunol"},{"key":"10.1016\/j.nano.2015.07.011_bb0220","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bbalip.2014.07.008","article-title":"Prostaglandin E-induced inflammation: relevance of prostaglandin E receptors","volume":"1851","author":"Kawahara","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nano.2015.07.011_bb0225","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nm.3221","article-title":"Inflammasome-derived IL-1beta production induces nitric oxide-mediated resistance to Leishmania","volume":"19","author":"Lima-Junior","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.nano.2015.07.011_bb0230","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-0625.2010.01172.x","article-title":"IL-1 signalling is dispensable for protective immunity in Leishmania-resistant mice","volume":"20","author":"Kautz-Neu","year":"2011","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.nano.2015.07.011_bb0235","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1172\/JCI79526","article-title":"An NLRP3 inflammasome-triggered Th2-biased adaptive immune response promotes leishmaniasis","volume":"125","author":"Gurung","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nano.2015.07.011_bb0240","doi-asserted-by":"crossref","first-page":"e1000871","DOI":"10.1371\/journal.ppat.1000871","article-title":"Keratinocytes determine Th1 immunity during early experimental leishmaniasis","volume":"6","author":"Ehrchen","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.nano.2015.07.011_bb0245","doi-asserted-by":"crossref","DOI":"10.1007\/s00403-015-1564-0","article-title":"Immunohistochemical evidence of stress and inflammatory markers in mouse models of cutaneous leishmaniosis","author":"Araujo","year":"2015","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.nano.2015.07.011_bb0250","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/jac\/dks159","article-title":"Glycyrrhizic acid suppresses Cox-2-mediated anti-inflammatory responses during Leishmania donovani infection","volume":"67","author":"Bhattacharjee","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.nano.2015.07.011_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2012.00059","article-title":"The influence of early neutrophil-Leishmania interactions on the host immune response to infection","volume":"2","author":"Ribeiro-Gomes","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.nano.2015.07.011_bb0260","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.4049\/jimmunol.172.7.4454","article-title":"Macrophage interactions with neutrophils regulate Leishmania major infection","volume":"172","author":"Ribeiro-Gomes","year":"2004","journal-title":"J Immunol"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963415001549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963415001549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T02:24:11Z","timestamp":1537410251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963415001549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1549963415001549"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2015.07.011","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of \u03b2-lapachone loaded in lecithin-chitosan nanoparticles for the topical treatment of cutaneous leishmaniasis in L. major infected BALB\/c mice","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2015.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}